CT

CTI BioPharma

- NASDAQ:CTIC
Last Updated 2024-04-19
  • Home | Targeted Therapies for Blood-Related Cancers | CTI BioPharma

  • Locations

    • Seattle WA

  • Total Funding (USD)

    85.1 million

  • Industries

    Mobile Apps

  • Security

    Type: ORD
    CUSIP: 12648L601
    ISIN: US12648L6011
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo